查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853365

神经病学病患监测市场依产品类型、监护模式、应用、最终用户、组件、部署模式、连接方式和技术划分－2025-2032年全球预测

Neurology Patient Monitoring Market by Product Type, Monitoring Mode, Application, End User, Component, Deployment Mode, Connectivity, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，神经病学病患监测市场规模将达到 104.9 亿美元，复合年增长率为 8.28%。

关键市场统计数据
基准年2024年 55.5亿美元
预计年份：2025年 60亿美元
预测年份 2032 104.9亿美元
复合年增长率（%） 8.28%

全面说明神经病学病患监测领域，重点关注临床驱动因素、技术融合以及相关人员的关键决策因素。

随着临床需求与技术创新以及医疗服务模式的转变，神经病学病患监测领域正迅速发展。本文首先阐述了推动投资和应用的关键临床因素，包括持续、准确的神经系统数据对于改善从急性到慢性疾病的治疗效果的重要性。此外，本文还概述了感测技术、讯号处理和软体分析的融合如何重新定义临床医生和看护者可用的即时监护方式。

在此背景下，相关人员必须了解设备模式、监控模式和护理环境之间的相互作用，以便为采购和部署决策提供基础。这一格局受到日趋成熟的医院基础设施、家庭和门诊护理模式、监管机构对资料完整性和网路安全的严格审查以及日益增长的互通性期望的影响。儘早了解这些因素，能够为读者评估未来几年将决定竞争优势和临床价值的技术、伙伴关係和能力奠定实际的基础。

感测技术、人工智慧主导的分析以及混合护理模式的快速发展如何重塑神经监测领域的临床工作流程、监管预期和竞争格局？

神经病学病患监测领域正经历着一场变革性的转变，这场转变正在加速临床应用，并重新定义竞争格局。感测器精度和讯号采集技术的进步带来了前所未有的洞察，而边缘运算和云端分析则实现了更快的解读和更及时的预警。同时，人工智慧融入解读流程，透过标记异常情况、确定病例优先顺序和缩短干预时间，增强了临床医生的工作流程，并将价值从原始数据收集转移到智慧的、情境感知的决策支援。

除了技术进步之外，医疗服务模式也从依赖病患监测转向融合门诊、家庭和医院环境的混合模式。这种转变需要更强大的连接架构、更灵活的部署方案以及以患者为中心的设备人体工学设计。法律规范也在不断发展，以应对医疗设备、资料隐私和上市后监管等问题，从而影响产品设计、检验策略和商业化路径。因此，随着这些变革力量的汇聚，那些能够将产品创新与临床工作流程、监管前瞻性和可扩展的支援模式相结合的机构，将获得更大的临床相关性和营运优势。

检验2025年关税政策的变化将如何推动供应链重组、采购多元化和策略采购转变，进而影响神经监测操作。

美国关税将于2025年实施，预计将在神经系统疾病病患监测生态系统中引发一系列营运和策略调整。进口零件和成品关税导致的成本变化可能会影响筹资策略，促使供应商重新评估其供应链布局，并考虑近岸外包和替代采购方式。随着各机构的调整，采购週期和供应商谈判可能会延长，从而影响设备的供应和临床应用速度。

除了直接的成本影响外，关税还可能促使供应商进行更广泛的整合，并推动可製造性设计，从而强调组件标准化和模组化架构。此类应对措施可能会促使设备製造商和製造外包之间加强合作，以实现本地化生产或重新设计产品，以减轻关税的影响。同时，医疗机构和系统可能会调整其供应商选择标准，优先考虑那些拥有稳健供应链和明确应对方案的供应商。从中长期来看，关税政策的累积影响将受到企业应对措施、外汇走势以及成本压力与维持不间断神经监测能力的临床需求之间不断变化的平衡的影响。

层级細項分析能够解读产品模式、监测模式、临床应用、最终用户环境、组件、部署选项、连接方式以及推动产品普及的技术方向。

透过细緻的市场区隔，我们可以发现创新和应用集中在哪些领域，以及哪些需求仍未被满足。就产品类型而言，脑电图 (EEG)、肌电图 (EMG)、颅内压监测系统和经颅都卜勒设备各自具有不同的临床应用场景、检验路径和整合要求，这就要求供应商调整其价值提案，以满足急性重症加护和长期门诊评估的不同需求。在监测模式方面，包括 EEG、EMG 和经颅都卜勒在内的非侵入性技术在门诊、睡眠和神经科科诊所具有广泛的应用前景，而磁脑图和颅内压监测等侵入性解决方案则可为重症加护决策提供更高保真度的信号。

癫痫监测需要高时间解析度和伪影抑制，神经退化性疾病监测强调纵向资料收集和患者舒适度，睡眠障碍监测需要居家友善、非侵入式设计，而中风监测则优先考虑快速检测并与急性护理路径整合。最终使用者细分揭示了门诊中心、居家照护机构和医院不同的采购週期和支援需求，每种机构都对人员配备、基础设施和报销等方面提出了特定的限制。组件细分区分了硬体、服务和软体收益源，凸显了软体主导的分析和售后临床支援日益增长的重要性。云端基础和本地部署解决方案之间的部署差异影响着资料管治、延迟和规模的考量，而有线连接与无线连接的选择则决定了安装的复杂性、移动性和患者体验。最后，人工智慧系统和传统方法之间的技术差异凸显了不同的开发重点：传统系统则强调确定性演算法和经过认证的讯号处理流程。将这些细分观点结合起来，可以更深入地了解临床价值的实现点、采用障碍的差异以及策略性投资在哪些方面能带来最大的回报。

全球医疗保健系统、监管框架和数位化准备程度的地域差异将如何影响优先事项、商业化和在地化策略

区域动态造就了不同的需求讯号和监管环境，进而影响产品策略、伙伴关係和商业化计画。在美洲，临床应用通常与优先考虑重症加护和研究的综合医疗系统和学术医疗中心一致，同时，受价值医疗和远距病患管理倡议的驱动，人们对家庭监测的兴趣也在迅速增长。在欧洲、中东和非洲，报销框架和医疗基础设施的差异造成了异质性格局，临床需求与成本控制之间的平衡必须根据各国的监管环境进行调整。

在亚太地区，医疗基础设施投资的加速成长、对本土製造能力的重视以及患者群体的快速扩张，都催生了对可扩展、高性价比监测解决方案的强劲需求。每个地区的数位化医疗发展现状、网路安全期望以及临床医务人员能力各不相同，这些因素共同影响产品在地化需求、通路策略和服务模式。因此，有意拓展业务的公司必须根据每个地区的具体情况，调整其监管规划、临床证据产生和营运支援策略。

本文探讨了产品传承、软体差异化、策略伙伴关係以及售后支援如何决定神经监测领域的竞争优势和市场接受度。

神经病学病患监测领域的竞争格局正由传统设备专长、新兴软体能力以及连接临床、技术和服务能力的策略联盟共同塑造。成熟的设备製造商拥有丰富的临床检验经验和分销网络，推动着医院层面的应用；而新参与企业和科技公司则凭藉软体定义产品、人工智慧和以用户为中心的设计脱颖而出。设备製造商、临床研究机构和云端平台供应商之间的伙伴关係正在加速证据产生和部署的规模化，从而创造出协作模式往往优于纯粹内部成长策略的环境。

此外，能够清楚展现售后临床支援、培训项目以及实际应用检验的公司，将优先获得采购决策者的青睐。对监管事务、品质系统和网路安全管治的投入，也使值得信赖的供应商与发展尚不成熟的企业区分开来。因此，能够有效整合经过验证的感测硬体、强大的讯号处理能力以及透明且经临床检验的分析技术，并透过可扩展的服务框架交付的企业，将拥有竞争优势。这种多维度的产品和市场执行策略，对于在复杂的医疗保健环境中获得持续发展至关重要。

指南领导力如何协调产品模组化、临床检验、部署灵活性和弹性采购以确保长期应用和营运弹性的指南

行业领导者应采取策略，协调产品开发、监管规划和商业性执行，以确保临床相关性和营运永续性。优先考虑模组化产品架构，实现组件重复使用和快速迭代，从而减轻供应链中断和关税带来的成本压力。同时，投资强大的资料管治、网路安全和临床检验项目，以支援人工智慧功能，并确保可解释性和临床医生的信任。这些投资将有助于跨司法管辖区的解决方案认证，并协助满足医院的IT和合规要求。

在商业性领域，我们为医院、门诊和家庭环境推行灵活的部署和定价模式，并强调提供整合硬体、软体和服务的捆绑式解决方案，以简化采购流程并展现后续护理的益处。为了累积长期证据并加速指南的采纳，我们优先发展能够快速扩展培训和技术援助的管道和支援基础设施，并建立策略性的临床伙伴关係关係。最后，我们积极主动地维护供应链和筹资策略，包括多元化的供应商、尽可能选择区域性生产方式以及遵循设计原则，从而在市场环境变化的情况下保护利润并确保医疗服务的连续性。

一种以证据主导的方法，结合了初步的临床参与、二次技术审查和结构化的分析方法，为决策者提供可操作的资讯。

本研究结合了与临床医生、医疗系统采购负责人和产品主管的定性访谈，并辅以对监管申报文件、临床文献和公开技术文件的二次分析，旨在构建神经病学病患监测技术及其应用动态的整体情况。研究综合了主要信息，以捕捉工作流程整合、临床优先事项和采购决策标准方面的经验性见解，而二次信息则提供了技术背景，并支持对设备功能和监管考虑进行三角验证。

分析方法包括技术比较评估、情境分析（用于评估政策和供应链事件的影响）以及细分市场映射（用于识别产品类型、监测模式、应用、最终用户、组件、部署模式、连接选项和技术方法等方面的未满足需求）。在整个检验临床医生的经验，并确保关于采纳驱动因素、监管里程碑和营运限制等假设的透明度。因此，该调查方法融合了实践者观点和结构化分析方法，旨在为决策者提供可操作的资讯。

本文简要概述了将创新转化为临床影响的策略要务，重点关注互通性、证据生成、营运韧性和以临床医生为中心的设计。

总之，由于技术成熟、医疗服务模式演变以及供应链动态变化，神经病学病患监测领域正处于曲折点。能够整合高保真感测技术、可解释分析和灵活部署方案的机构，将更有能力满足医院、门诊中心和居家照护机构的多样化需求。同样重要的是，这些机构还需具备应对复杂监管环境、透过真实世界证据证明临床价值以及在政策和经济逆风中保持稳健的供应链和生产策略的能力。

相关人员在规划下一步行动时，应重点关注互通性、以临床医生为中心的设计以及上市后性能监测，以确保临床应用的持续性和患者获益。透过协调产品开发、证据产生和商业性执行，领导者可以将技术前景转化为可衡量的临床影响和持久的组织优势。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合人工智慧驱动的预测分析平台，用于早期侦测神经系统事件
  • 推出一款穿戴式脑电图感测器系统，可实现对癫痫发作的连续远端监测。
  • 扩展云端基础的远端监控网络，以支援神经病学患者即时数据分析。
  • 非侵入性颅内压监测设备在水脑症早期诊断的应用
  • 采用标准化资料框架以提高神经监测系统之间的互通性
  • 开发人工智慧睡眠和运动追踪工具，用于全面的神经退化护理
  • 整合行动应用程式介面以增强慢性神经系统疾病管理中的患者自我监测

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 神经病学病患监测市场（依产品类型划分）

  • 脑电图
  • 肌电图
  • ICP监测系统
  • TCD设备

9. 按监测模式分類的神经病学病患监测市场

  • 侵入性
    • 脑电皮质记录
    • ICP监测
  • 非侵入性
    • 脑电图
    • 肌电图
    • TCD

第十章 按应用分類的神经病学病患监测市场

  • 癫痫监测
  • 神经退化性疾病监测
  • 睡眠障碍监测
  • 中风监测

第十一章 神经病学病患监测市场（按最终用户划分）

  • 门诊治疗中心
  • 居家照护环境
  • 医院

第十二章 神经病学病患监测市场（按组件划分）

  • 硬体
  • 服务
  • 软体

第十三章 依部署模式分類的神经病学病患监测市场

  • 云端基础
  • 本地部署

第十四章 神经病学病患监测市场：连结性与性别

  • 有线
  • 无线的

第十五章 神经病学病患监测市场（依技术划分）

  • 人工智慧
  • 传统的

第十六章 神经病学病患监测市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十七章 神经病学病患监测市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十八章 各国神经病学病患监测市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十九章 竞争情势

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Koninklijke Philips NV
    • GE HealthCare Technologies Inc.
    • Nihon Kohden Corporation
    • Natus Medical Incorporated
    • Dragerwerk AG & Co. KGaA
    • Masimo Corporation
    • Medtronic plc
    • Compumedics Limited
    • Cadwell Laboratories, Inc.
    • Ceribell, Inc.
Product Code: MRR-3A2E844FCDB5

The Neurology Patient Monitoring Market is projected to grow by USD 10.49 billion at a CAGR of 8.28% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.55 billion
Estimated Year [2025] USD 6.00 billion
Forecast Year [2032] USD 10.49 billion
CAGR (%) 8.28%

A comprehensive orientation to the neurology patient monitoring landscape that clarifies clinical drivers, technological convergence, and critical decision levers for stakeholders

The neurology patient monitoring domain is undergoing rapid evolution as clinical demand intersects with technological innovation and shifting care delivery paradigms. This introduction sets the stage by clarifying the clinical imperatives driving investment and adoption, including the need for continuous, accurate neurological data to improve outcomes across acute and chronic conditions. It also outlines how convergence among sensing technologies, signal processing, and software-enabled analytics is redefining what real-time monitoring can deliver for clinicians and caregivers.

Against this backdrop, stakeholders must understand the interplay of device modalities, monitoring modes, and care environments that shape procurement and deployment decisions. The landscape is influenced by hospital infrastructure, the maturation of home and ambulatory care models, regulatory scrutiny of data integrity and cybersecurity, and growing expectations for interoperability. By framing these forces early, readers gain a practical foundation for evaluating technologies, partnerships, and capabilities that will determine competitive differentiation and clinical value in the coming years.

How rapid advances in sensing, AI-driven analytics, and hybrid care models are reshaping clinical workflows, regulatory expectations, and competitive moats in neurology monitoring

The neurology patient monitoring space is experiencing transformative shifts that are accelerating clinical adoption and redefining competitive dynamics. Advancements in sensor fidelity and signal acquisition are enabling previously unobtainable insights, while edge processing and cloud-enabled analytics allow for faster interpretation and actionable alerts. Simultaneously, the integration of artificial intelligence into interpretation pipelines is augmenting clinician workflows by flagging anomalies, prioritizing cases, and reducing time to intervention, thus shifting the locus of value from raw data capture to intelligent, context-aware decision support.

In addition to technological progress, care-delivery models are shifting away from exclusive reliance on inpatient monitoring toward hybridized approaches that blend ambulatory, home-based, and hospital settings. This transition requires more robust connectivity architectures, flexible deployment options, and an emphasis on patient-centric device ergonomics. Regulatory frameworks are also evolving to address software as a medical device, data privacy, and post-market surveillance, which in turn influences product design, validation strategies, and commercialization pathways. Consequently, organizations that align product innovation with clinical workflows, regulatory foresight, and scalable support models will capture greater clinical relevance and operational traction as these transformative forces converge.

Examining how tariff policy changes in 2025 can prompt supply chain reconfiguration, sourcing diversification, and strategic procurement shifts affecting neurology monitoring operations

The introduction of United States tariffs in 2025 has potential to create a cascade of operational and strategic adjustments across the neurology patient monitoring ecosystem. Tariff-driven cost changes for imported components and finished devices can influence procurement strategies, prompting suppliers to reassess supply chain footprints and to explore near-shoring or alternative sourcing. As organizations adapt, procurement timelines and vendor negotiations may extend, which could affect device availability and the pacing of deployments in clinical settings.

Beyond immediate cost implications, tariffs can catalyze broader supplier rationalization and design-for-manufacturability efforts that emphasize component standardization and modular architectures. These responses may spur greater collaboration between device manufacturers and contract manufacturers to localize production or redesign products to reduce tariff exposure. At the same time, providers and health systems might prioritize vendors with resilient supply chains and clear mitigation plans, thereby reshaping vendor selection criteria. Over the medium term, the cumulative effects of tariff policy will be mediated by corporate responses, currency movements, and the evolving balance between cost pressures and the clinical imperative to maintain uninterrupted neurologic monitoring capabilities.

A layered segmentation analysis that deciphers product modalities, monitoring modes, clinical applications, end-use environments, components, deployment options, connectivity, and technology vectors driving adoption

A nuanced segmentation lens illuminates where innovation and adoption are concentrated and where unmet needs persist. When considering product categories, electroencephalography (EEG), electromyography (EMG), intracranial pressure monitoring systems, and transcranial Doppler devices each carry distinct clinical use cases, validation pathways, and integration requirements, and vendors must tailor value propositions to the differential needs of acute neuro-critical care versus longitudinal ambulatory assessment. In terms of monitoring mode, invasive solutions such as electrocorticography and intracranial pressure monitoring offer high-fidelity signals for critical care decision making, while non invasive techniques including EEG, EMG, and transcranial Doppler provide broader applicability across outpatient, sleep, and neurology clinic contexts, creating complementary adoption curves and differing requirements for clinician training and regulatory clearance.

Application-focused segmentation further refines opportunity areas, with epilepsy monitoring demanding high temporal resolution and artifact rejection; neurodegenerative disease monitoring emphasizing longitudinal data capture and patient comfort; sleep disorder monitoring requiring home-friendly, minimally obtrusive designs; and stroke monitoring prioritizing rapid detection and integration with acute care pathways. End-user distinctions reveal distinct procurement cycles and support needs across ambulatory care centers, home care settings, and hospitals, each of which imposes specific constraints related to staffing, infrastructure, and reimbursement. Component segmentation separates hardware, services, and software revenue streams and underscores the rising importance of software-driven analytics and post-sale clinical support. Deployment mode differences between cloud-based and on-premise solutions shape data governance, latency, and scale considerations, while connectivity choices between wired and wireless determine installation complexity, mobility, and patient experience. Finally, technology differentiation between AI-enabled systems and traditional approaches highlights divergent development priorities: AI-enabled offerings require robust training datasets, explainability, and post-market performance monitoring, whereas traditional systems focus on deterministic algorithms and certified signal processing pipelines. Taken together, these segmentation perspectives enable a layered understanding of where clinical value is realized, how adoption barriers vary, and where strategic investments will yield the greatest returns.

How geographic differences in healthcare systems, regulatory frameworks, and digital readiness shape prioritization, commercialization, and localization strategies across global regions

Regional dynamics create differentiated demand signals and regulatory contexts that influence product strategy, partnerships, and commercialization plans. In the Americas, clinical adoption often aligns with integrated health systems and academic medical centers that prioritize advanced monitoring for critical care and research, alongside a rapidly growing interest in home-based monitoring driven by value-based care and remote patient management initiatives. Across Europe, Middle East & Africa, variations in reimbursement frameworks and healthcare infrastructure result in a heterogeneous landscape where clinical needs are balanced against cost containment imperatives, and where local regulatory pathways necessitate tailored evidence generation and distribution strategies.

In the Asia-Pacific region, accelerating investment in healthcare infrastructure, a strong emphasis on domestic manufacturing capability, and rapidly expanding patient populations are creating vigorous demand for scalable, cost-effective monitoring solutions. Each of these regional contexts also differs in digital health readiness, cybersecurity expectations, and clinical workforce capacity, which collectively shape product localization requirements, channel strategies, and service models. Therefore, firms seeking to expand their footprint must align regulatory planning, clinical evidence generation, and operational support with the distinct priorities and constraints present within each geographic region.

Insights into how product heritage, software differentiation, strategic partnerships, and post-sale support determine competitive advantage and adoption trajectories in neurology monitoring

Competitive dynamics in the neurology patient monitoring space are being defined by a combination of legacy device expertise, emergent software capabilities, and strategic alliances that bridge clinical, technological, and services competencies. Established device manufacturers contribute deep clinical validation experience and distribution networks that facilitate hospital-level adoption, while newer entrants and technology firms are differentiating through software-defined offerings, artificial intelligence, and user-centric design. Partnerships between device makers, clinical research entities, and cloud-platform providers are enabling accelerated evidence generation and deployment scalability, creating an environment where collaborative models often outpace purely organic growth strategies.

Moreover, companies that demonstrate clear post-sale clinical support, training programs, and evidence of real-world performance are gaining preferential access to procurement decision makers. Investment in regulatory affairs, quality systems, and cybersecurity governance further distinguishes credible suppliers from less mature players. As a result, competitive advantage accrues to organizations that can effectively combine validated sensing hardware, robust signal processing, and transparent, clinically validated analytics delivered through scalable service frameworks. This multi-dimensional approach to product and market execution is increasingly essential for achieving sustained traction in complex healthcare environments.

Action-oriented guidance for leaders to align product modularity, clinical validation, deployment flexibility, and resilient sourcing to secure long-term adoption and operational resilience

Industry leaders should pursue a coordinated strategy that aligns product development, regulatory planning, and commercial execution to capture clinical relevance and operational sustainability. Prioritize modular product architectures that enable component reuse and rapid iteration, thereby reducing exposure to supply chain disruptions and tariff-driven cost pressures. Simultaneously, invest in robust data governance, cybersecurity, and clinical validation programs that support AI-enabled functionality while ensuring explainability and clinician trust. These investments will make it easier to certify solutions across jurisdictions and to satisfy hospital IT and compliance requirements.

In the commercial realm, cultivate flexible deployment and pricing models that accommodate hospital, ambulatory, and home-based settings; emphasize bundled offerings that integrate hardware, software, and services to simplify procurement and to demonstrate downstream care benefits. Forge strategic clinical partnerships to build longitudinal evidence and to accelerate guideline adoption, and prioritize channels and support infrastructures that can rapidly scale training and technical assistance. Finally, maintain a proactive supply chain and sourcing strategy that includes diversified suppliers, regional manufacturing options where feasible, and design-for-manufacture principles to preserve margin and ensure continuity of care delivery as market conditions evolve.

An evidence-driven methodology combining primary clinical engagement, secondary technical review, and structured analytical approaches to produce actionable intelligence for decision makers

This research integrates primary qualitative engagements with clinicians, health system procurement leaders, and product executives, supplemented by secondary analysis of regulatory filings, clinical literature, and publicly available technical documentation to construct a holistic view of neurology patient monitoring technologies and adoption dynamics. Primary inputs were synthesized to capture experiential insights on workflow integration, clinical priorities, and procurement decision criteria, while secondary sources provided technical context and supported triangulation of device capabilities and regulatory considerations.

Analytical methods included comparative technology assessment, scenario analysis to evaluate the implications of policy and supply chain events, and segmentation mapping to identify unmet needs across product types, monitoring modes, applications, end users, components, deployment models, connectivity options, and technology approaches. Throughout the analysis, emphasis was placed on validation against clinician experience and on the transparency of assumptions related to adoption drivers, regulatory milestones, and operational constraints. The methodology therefore blends practitioner-informed perspectives with structured analytical techniques to provide actionable intelligence for decision makers.

A succinct synthesis of strategic imperatives emphasizing interoperability, evidence generation, resilient operations, and clinician-centered design to translate innovation into clinical impact

In conclusion, the neurology patient monitoring landscape is at an inflection point driven by technological maturation, evolving care delivery models, and shifting supply chain dynamics. Organizations that integrate high-fidelity sensing, explainable analytics, and flexible deployment options will be best positioned to meet the diverse needs of hospitals, ambulatory centers, and home care environments. Equally important is the ability to navigate regulatory complexity, to demonstrate clinical value through real-world evidence, and to maintain resilient supply and manufacturing strategies in the face of policy and economic headwinds.

As stakeholders plan next steps, they should focus on interoperability, clinician-centric design, and post-market performance monitoring to ensure sustained clinical adoption and patient benefit. By aligning product development, evidence generation, and commercial execution, leaders can convert technological promise into measurable clinical impact and durable organizational advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven predictive analytics platforms for early neurological event detection
  • 5.2. Deployment of wearable EEG sensor systems enabling continuous remote seizure monitoring
  • 5.3. Expansion of cloud-based telemonitoring networks to support real-time neurology patient data analytics
  • 5.4. Emergence of non-invasive intracranial pressure monitoring devices for early diagnosis of hydrocephalus
  • 5.5. Adoption of standardized data frameworks to enhance interoperability across neurology monitoring systems
  • 5.6. Development of AI-enabled sleep and movement tracking tools for comprehensive neurodegenerative care
  • 5.7. Integration of mobile application interfaces to empower patient self-monitoring in chronic neurological management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurology Patient Monitoring Market, by Product Type

  • 8.1. EEG
  • 8.2. EMG
  • 8.3. ICP Monitoring System
  • 8.4. TCD Device

9. Neurology Patient Monitoring Market, by Monitoring Mode

  • 9.1. Invasive
    • 9.1.1. Electrocorticography
    • 9.1.2. ICP Monitoring
  • 9.2. Non Invasive
    • 9.2.1. EEG
    • 9.2.2. EMG
    • 9.2.3. TCD

10. Neurology Patient Monitoring Market, by Application

  • 10.1. Epilepsy Monitoring
  • 10.2. Neurodegenerative Disease Monitoring
  • 10.3. Sleep Disorder Monitoring
  • 10.4. Stroke Monitoring

11. Neurology Patient Monitoring Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Home Care Settings
  • 11.3. Hospitals

12. Neurology Patient Monitoring Market, by Component

  • 12.1. Hardware
  • 12.2. Services
  • 12.3. Software

13. Neurology Patient Monitoring Market, by Deployment Mode

  • 13.1. Cloud Based
  • 13.2. On Premise

14. Neurology Patient Monitoring Market, by Connectivity

  • 14.1. Wired
  • 14.2. Wireless

15. Neurology Patient Monitoring Market, by Technology

  • 15.1. AI Enabled
  • 15.2. Traditional

16. Neurology Patient Monitoring Market, by Region

  • 16.1. Americas
    • 16.1.1. North America
    • 16.1.2. Latin America
  • 16.2. Europe, Middle East & Africa
    • 16.2.1. Europe
    • 16.2.2. Middle East
    • 16.2.3. Africa
  • 16.3. Asia-Pacific

17. Neurology Patient Monitoring Market, by Group

  • 17.1. ASEAN
  • 17.2. GCC
  • 17.3. European Union
  • 17.4. BRICS
  • 17.5. G7
  • 17.6. NATO

18. Neurology Patient Monitoring Market, by Country

  • 18.1. United States
  • 18.2. Canada
  • 18.3. Mexico
  • 18.4. Brazil
  • 18.5. United Kingdom
  • 18.6. Germany
  • 18.7. France
  • 18.8. Russia
  • 18.9. Italy
  • 18.10. Spain
  • 18.11. China
  • 18.12. India
  • 18.13. Japan
  • 18.14. Australia
  • 18.15. South Korea

19. Competitive Landscape

  • 19.1. Market Share Analysis, 2024
  • 19.2. FPNV Positioning Matrix, 2024
  • 19.3. Competitive Analysis
    • 19.3.1. Koninklijke Philips N.V.
    • 19.3.2. GE HealthCare Technologies Inc.
    • 19.3.3. Nihon Kohden Corporation
    • 19.3.4. Natus Medical Incorporated
    • 19.3.5. Dragerwerk AG & Co. KGaA
    • 19.3.6. Masimo Corporation
    • 19.3.7. Medtronic plc
    • 19.3.8. Compumedics Limited
    • 19.3.9. Cadwell Laboratories, Inc.
    • 19.3.10. Ceribell, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASIA-PACIFIC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. ASEAN NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. GCC NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. EUROPEAN UNION NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BRICS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. G7 NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. NATO NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 34. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 35. NEUROLOGY PATIENT MONITORING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 36. NEUROLOGY PATIENT MONITORING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEUROLOGY PATIENT MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ELECTROCORTICOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ICP MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EEG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EMG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TCD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY EPILEPSY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NEURODEGENERATIVE DISEASE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SLEEP DISORDER MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY STROKE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CLOUD BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY WIRELESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY AI ENABLED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NEUROLOGY PATIENT MONITORING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY MONITORING MODE, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY NON INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY DEPLOYMENT MODE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY CONNECTIVITY, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE NEUROLOGY PATIENT MONITORING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST NEUROLOGY PATIENT MONITORING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (US